Peer Review History
| Original SubmissionDecember 18, 2019 |
|---|
|
PONE-D-19-35012 Evolutionary conservation and multilevel post-translational control of S-adenosyl-homocysteine-Hydrolase in land plants PLOS ONE Dear Dr Kangasjarvi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. please find attached reviews from three different reviewers. With kind regards ============================== We would appreciate receiving your revised manuscript by Jun 11 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Evangelia V. Avramidou, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 'This work was financially supported by Academy of Finland project 307719 to SK, 325122 to JP, and the Academy of Finland Center of Excellence in Primary Producers 2014-2019 (307335). SA and MR were funded by the University of Turku Doctoral Programme in Molecular Life Sciences, the Turku University Foundation and the Finnish Cultural Foundation Varsinais-Suomi Regional Fund. MB was funded by the University of Helsinki.' We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 'This work was financially supported by Academy of Finland (www.aka.fi) project 307719 to SK, 325122 to JP, and the Academy of Finland Center of Excellence in Primary Producers 2014-2019 (307335). SA and MR were funded by the University of Turku Doctoral Programme in Molecular Life Sciences (https://www.utu.fi/en/research/utugs/doctoral-programme-in-molecular-life-sciences). MR was also funded by the Turku University Foundation (https://www.yliopistosaatio.fi/en/) and the Finnish Cultural Foundation Varsinais-Suomi Regional Fund (https://skr.fi/en/regional-funds/varsinais-suomi-regional-fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.'
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this paper, the Authors describe evolutionary conservation, as well as biochemical characterization of S-adenosyl-L-homocysteine hydrolase in land plants including multi-level post-translational control of the enzyme. They found, that an oligomeric SAHH complex 4 corresponds to a homotetrameric form of SAHH. The manuscript is generally well written and the drawn conclusions are mostly supported by the experimental results. However, I have some concern about the results and conclusions related to the oligomeric state of SAHH and a composition of the complex 4. Taken together, the paper is a strong candidate for this journal, if the authors can address all of the shortcomings in the experiments and interpretations mentioned below. MAJOR points 1. The Authors discuss on different oligomeric forms of plant SAHHs in a light of physiological (tetramer) and artificial (dimer) conditions. It should be stress in the manuscript, that the dimeric form of Lupinus luteus SAHH was established within in vivo studies (gel filtration, crystallography etc.). Also, structural studies of L. luteus enzyme were conducted with a recombinant, not post-translationally modified enzyme. 2. Did the Authors considered e.g. gel filtration analysis (or some others like Dynamic Light Scattering) to establish oligomeric state of recombinant Arabidopsis thaliana SAHH , as well as the isolated complex 4? 3. The Authors indicate a molecular mass of the complex 4 of about 200 kDa, which corresponds to the tetrameric form of plant SAHase (~210 kDa). However, this molecular mass also could correspond to the heteroligomer composed of two SAHH and two ADK molecules (see Lee et al. 2012, reference 18 in the manuscript). Did the Authors exclude a presence of ADK in complex 4? 4. Did the Authors considered SDS-PAGE separation for the isolated and purified complex 4 visualized with SYPRO or other dye? The result should be definitive for the establishment of a composition (homo- vs. heterooligomer) of complex 4 (2D gels are a bit blurred, might be affected by a presence of SDS). 5. How the authors obtained anti-SAHH antibody? Did they use recombinant SAHH or isolated complex 4 as an antigen? If the complex 4 was used, the antibody could be used in detection of other possible (if any) components of the complex. MINOR points 1. The full and correct name of the enzyme is S-adenosyl-L-homocysteine hydrolase. The name used in the title should be replaced with the correct one. 2. Figure 3 has three panels (A-D), whereas the figure 3 caption describes panels A-C. Also the description is shifted. Reviewer #2: This manuscript addresses an interesting issue on the regulation of SAHH in land plants, but at the moment the manuscript is premature. The experiments performed are minimal, without information on their reproducibility, and currently do not support the conclusions. Major modifications are required before publications. Major comments: Figure 2 and related text (methods): Please include appropriate negative control of wild-type Arabidopsis tissues imaged at the same magnification, same exposure time and brightness/contrast settings. For subcellular localization, e.g. nucleolus, please include higher magnification pictures. This should pose no problem since the authors have access to a confocal microscope. In the methods or elsewhere appropriate, please specify the exposure time and brightness/contrast settings for all pictures shown. Same comment for S1 video, show negative control using non-GFP tissues, since plant tissues can be highly auto fluorescent the wavelengths used for GFP. Figure 3 and related text: Description of the method used for the identification of the proteins on the 2D gels cannot be found in the manuscript. Were mass spectrometric methods used? Please make sure the methods employed are described in the revision. In addition, the panels 3C and 3D are not correctly described in the text or the figure 3 legend. Figure 4 and associated text: There are a few problems with this figure. Firstly, the identification of 6 complexes containing SAHH1 in panel C is questionable because the number of bands in each species is different. Moreover, the specificity of the �SAHH antibody has not been thoroughly investigated, and the presence of SAHH1 in these complexes has not been confirmed by any analytical methods (mass spectrometry for example), or appropriate negative controls. This is needed to support the conclusions. Without this information about the proteins actually present in the complexes, to name the most intense band seen in each lane as the same conserved “SAHH complex 4” is not an appropriate conclusion. Figure 5 and associated text: Same as with Fig 4; without identifying these complexes, you cannot write they are the same, responding in opposite ways to light stress. You must confirm the presence of SAHH1 in each complex in each species to make the conclusion you are making, else you need to rewrite your conclusions. Throughout the paper: There is no statistical tests performed on any data shown, and we do not know whether the data shown are representative of reproduced experiments. When investigating the changes in complex abundance, for example in Fig. 5, it would be helpful to show three experimental replicates for each species and treatment so that we have an idea of the reproducibility of the changes, and you would be able to make statistical analysis on these changes. Minor comments: Line 66: ….is the only known eukaryotic…. Line 142: The samples were centrifuged at 18,000 g…. Line 272-274: sentence is not understandable. Please rewrite. Arabidopsis and Physcomitrella and other genera names should be italicized throughout the manuscript, even when the species name is omitted. Reviewer #3: A few Comments: 1. Line 30: evolutionary conservation and multilevel post-translational control of SAHH in land plants. -> Authors only checked phosphorylation in current manuscript. But, authors mentioned multilevel post-translational modification. Authors need to change the sentence. 2. Line 35: in the levels of protein complex formation and post-translational modification of this. -> Authors need to change the sentence “post-translational modification” to “phosphorylation” and then trim the whole sentence. 3. Line 278: SAHH in multiple spots with different pIs and three different molecular masses (Fig 3B). ->Error found: Fig. 3B should be changed to Fig.3C. ->I do not know the positions of the complex spots. Authors need to indicate complexes 1,2,3,4,5,6 in the Figure (for example by arrows). 4. Line 285-288: In parallel, a control sample of equal protein content was separated on an SDS-PAGE devoid of urea. Immunoblotting of the Phostag gels with anti-SAHH antibody revealed slow-migrating protein spots, indicative of SAHH phosphorylation in complexes 3, 4 and 5 (Fig 3C). ->Error found: Fig. 3C should be changed to Fig.3D. -> Again, I do not know the positions of the complex spots. Authors need to indicate non-modified complexes 1,2,3,4,5,6 in the Figure (for example by arrows). In addition, I cannot see slow-migrating protein spots. Could you please also indicate slow-migrating protein spots in the Figure or replace the Figure with new one? 5. Figure 3B makes me confuse and feel uncomfortable. Can authors explain the results more precisely but concisely? 6. Authors examined the effects of SDS and DTT on the oligimerization of SAAH. What is the meaning of these experiments in current manuscript? We can expect the effects of ionic detergents and reducing agents on protein conformation and oligomerization. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Krzysztof Brzezinski Reviewer #2: Yes: Jean-Michel Fustin Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-35012R1 Evolutionary conservation and post-translational control of S-adenosyl-L-homocysteine hydrolase in land plants PLOS ONE Dear Dr. Kangasjarvi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 01 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Evangelia V. Avramidou, PhD Academic Editor PLOS ONE Additional Editor Comments (if provided): Dear authors, although your manuscript has been improved, the comments which are raised from one reviewer was not answered, and he proposed a second major revision round. I also agree with his comments, so please answer his comments in order to further improve your manuscript. With kind regards [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: No Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: No Reviewer #3: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: No Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The Authors have addressed my comments. Therefore, the present manuscript can be accepted for publication. I have identified a few of remaining concerns/minor corrections that that also need to be made in a final revision: 1. Page 4, line 93: is “in vivo”, should be: “in vitro”. 2. Page 18, Table 1: It is sufficient to report identity/similarity values with two - three significant digit after the period. Reviewer #2: The authors seemed to have ignored most of the comments of the reviewers. We have all asked for major revisions, and yet none of the main figures were modified. Moreover, some of their answers have brought up new problems. The manuscript still appears very rough and premature. There is still only on replicate shown in Fig. 5. If the authors have really performed the experiments three times as they now specify, there should be no problem showing in sup info the other two replicates. Ideally, though, as I previously asked, to have 2 or 3 replicates lanes (from different biological samples) for each treatment would make the manuscript much more believable. The statistical test used in Fig S4 is apparently written to be t-test. This is not appropriate as changes in C2 and C4 for one species are not independent (same lane) and should be analysed together. There is no significance shown for C2 in S4 (C2 label is missing, by the way) despite more pronounced differences in bar heights, does it mean it was not significant or the significance label was also forgotten? The text does not really make it clear either. Which changes were significant? Quantification of gel lanes from Fig. 5 and statistical analyses shown in Fig. S4 are actually very important and belong to the main figure, especially since light-dependent changes in SAHH complex are mentioned in the abstract. The authors now seem to have used MS to identify spots shown in S3, but S3 just shows a picture of a 2D gel without any annotations on which spots were analysed to confirm the presence of SAHH. The authors should be precise about what was analysed (which 2D gel, which spot(s)) this time by MS. While the discussion sometimes goes well beyond what is actually shown in the manuscript, there is not discussion about the contribution of SAHH1 and SAHH2 in the protein complexes the authors describe. Does their antibody also recognise SAHH2? If not, why not? In mammals Ahcyl1/Ahcyl2 interacts with Ahcy and so presumably also in plants. The authors indeed mention SAHH2 in the introduction, but then completely forget about it in the results and the discussion. If the authors really have used MS, they should have been able to differentiate between SAHH1 and SAHH2. Why not? Really, I can't recommend this manuscript for publication at the moment. Reviewer #3: Most of reviewers' comments were properly corrected and revised according to reviewers' points and suggestions. But I still feel few parts of the manuscript were not clear because of data quality. So I would like to tell authors one thing that authors need to prepare your data clearer next time. Anyhow, I recommend the paper for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Krzysztof Brzezinski Reviewer #2: Yes: Jean-Michel Fustin Reviewer #3: Yes: Hak Soo Seo [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Evolutionary conservation and post-translational control of S-adenosyl-L-homocysteine hydrolase in land plants PONE-D-19-35012R2 Dear Dr. Kangasjarvi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Evangelia V. Avramidou, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have addressed my comments adequately. The manuscript now provide more solid evidence about the conservation and regulation of SAHH and is ready for publication. The light response is particularly interesting because it would indicate that methyl metabolism as a whole is light responsive. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Jean-Michel Fustin |
| Formally Accepted |
|
PONE-D-19-35012R2 Evolutionary conservation and post-translational control of S-adenosyl-L-homocysteine hydrolase in land plants Dear Dr. Kangasjärvi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Evangelia V. Avramidou Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .